5J3 Stock Overview
A medical technology company, develops and sells point-of-care platforms that utilizes electrical impedance spectroscopy for the evaluation of skin disorders in Europe, the United States, North America, Asia, Oceania, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 6/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
SciBase Holding AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.02 |
| 52 Week High | SEK 0.043 |
| 52 Week Low | SEK 0.0002 |
| Beta | 1.23 |
| 1 Month Change | 20.99% |
| 3 Month Change | 1.03% |
| 1 Year Change | 68.97% |
| 3 Year Change | -94.56% |
| 5 Year Change | n/a |
| Change since IPO | -93.76% |
Recent News & Updates
Recent updates
Shareholder Returns
| 5J3 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 92.2% | 1.5% | 2.5% |
| 1Y | 69.0% | -11.3% | 14.4% |
Return vs Industry: 5J3 exceeded the German Medical Equipment industry which returned -11.3% over the past year.
Return vs Market: 5J3 exceeded the German Market which returned 14.4% over the past year.
Price Volatility
| 5J3 volatility | |
|---|---|
| 5J3 Average Weekly Movement | 138.7% |
| Medical Equipment Industry Average Movement | 5.7% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in DE Market | 12.8% |
| 10% least volatile stocks in DE Market | 3.1% |
Stable Share Price: 5J3's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 5J3's weekly volatility has decreased from 1078% to 139% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 32 | Pia Renaudin | scibase.com |
SciBase Holding AB (publ), a medical technology company, develops and sells point-of-care platforms that utilizes electrical impedance spectroscopy for the evaluation of skin disorders in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin cancer; and assess skin barrier and inflammation.
SciBase Holding AB (publ) Fundamentals Summary
| 5J3 fundamental statistics | |
|---|---|
| Market cap | €7.73m |
| Earnings (TTM) | -€5.59m |
| Revenue (TTM) | €2.72m |
2.8x
P/S Ratio-1.4x
P/E RatioIs 5J3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 5J3 income statement (TTM) | |
|---|---|
| Revenue | SEK 29.71m |
| Cost of Revenue | SEK 8.63m |
| Gross Profit | SEK 21.08m |
| Other Expenses | SEK 82.20m |
| Earnings | -SEK 61.12m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
May 13, 2025
| Earnings per share (EPS) | -0.28 |
| Gross Margin | 70.96% |
| Net Profit Margin | -205.77% |
| Debt/Equity Ratio | 0% |
How did 5J3 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/05 02:28 |
| End of Day Share Price | 2025/05/05 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
SciBase Holding AB (publ) is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Christian Lee | Pareto Securities |
| Mats Hyttinge | Redeye |